Osiris Therapeutics Inc. (OSIR) Sees Large Volume Increase
Shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) saw an uptick in trading volume on Friday . 70,104 shares traded hands during mid-day trading, an increase of 35% from the previous session’s volume of 51,871 shares.The stock last traded at $5.48 and had previously closed at $5.29.
The stock has a 50 day moving average price of $5.14 and a 200 day moving average price of $5.68. The stock has a market cap of $188.45 million and a price-to-earnings ratio of 130.24.
A hedge fund recently raised its stake in Osiris Therapeutics stock. GSA Capital Partners LLP boosted its stake in shares of Osiris Therapeutics Inc. (NASDAQ:OSIR) by 10.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 98,901 shares of the company’s stock after buying an additional 9,702 shares during the period. GSA Capital Partners LLP owned about 0.29% of Osiris Therapeutics worth $1,027,000 as of its most recent SEC filing.
Osiris Therapeutics, Inc is a medical products company. The Company is focused on developing and marketing products in regenerative medicine, including bioengineering, stem cell research and viable tissue based products. The Company’s offers products in orthopedics, sports medicine and wound care, including Cartiform, BIO4 and Grafix.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.